Inventiva IVA
NASDAQ IVA
$3.55 +0.29 (+8.90%)
At close: Oct 21, 2026 · 4:00 PM EDT

Inventiva (IVA) Current Deferred Revenue (2018 - 2024)

Updated

Inventiva's Current Deferred Revenue was $1.19 million in Q2 2025, compared with $3,231 a year earlier.

Analysis

Inventiva (IVA) Current Deferred Revenue (2018 - 2024) Analysis & Trends

At the end of FY2023, Current Deferred Revenue at Inventiva came in at $6,456, up 5.5% from FY2022.

  • Current Deferred Revenue shows a five-year compound annual growth rate of -60.2% (FY2018 to FY2023).
  • In earlier years, Current Deferred Revenue was $6,121 in FY2022.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,136.97 Bn 1,105.55 Bn 19.71 Bn
2 Johnson & Johnson 619.72 Bn 538.25 Bn 17.26 Bn
3 AbbVie 503.40 Bn 476.52 Bn 12.70 Bn
4 Merck 370.15 Bn 324.53 Bn 12.21 Bn
5 Novartis Ag 298.64 Bn 262.63 Bn 11.24 Bn
6 Astrazeneca 261.07 Bn 234.76 Bn 12.86 Bn
7 Amgen 237.00 Bn 192.40 Bn 7.24 Bn
8 Gilead Sciences 191.24 Bn 165.43 Bn 6.22 Bn
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn
10 Inventiva 665.95 Mn -164.50 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2024 3,212.54
Dec 31, 2023 6,640.91
Jun 30, 2023 6,520.82
Dec 31, 2022 6,396.45
Dec 31, 2018 626,909.02
API Access

Inventiva Current Deferred Revenue API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=current-deferred-revenue&ticker=IVA&period=max&api_key=YOUR_API_KEY